期刊
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY
卷 28, 期 2, 页码 191-201出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bpa.2014.03.005
关键词
post-operative pain; procedure specific; multimodal analgesia; preventive analgesia; evidence-based medicine; clinical decision support systems
资金
- Pfizer, New York, USA
- Grunenthal (Stolberg, Germany)
- Pfizer, NY
- Pacira, NJ
- Merck, NY
- CSI (Melbourne, VIC, Australia)
- Janssen Pharmaceuticals (Sydney, NSW, Australia)
- Mundipharma (Sydney, NSW, Australia)
- Pfizer Inc., NY
- Phosphagenics (Melbourne, VIC, Australia)
- ix Biopharma (Singapore, Singapore)
Optimal dynamic pain relief is a prerequisite for optimizing postoperative recovery and reducing morbidity and convalescence. Procedure-specific pain management initiative aims to overcome the limitations of conventional guidelines and provide health-care professionals with practical recommendations formulated in a way that facilitates clinical decision making across all the stages of the perioperative period. The procedure-specific evidence is supplemented with data from other similar surgical procedures and clinical practices to balance benefits and risks of each analgesic technique. There is emphasis on the use of multimodal analgesia and preventive analgesia aimed at reducing central sensitization. Importantly, the benefits of dynamic pain relief may only be realized if other aspects of perioperative care such as the use of minimally invasive surgery, approaches to reduce stress responses, optimizing fluid therapy and optimizing post-operative nursing care with early mobilization and oral feeding are utilized. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据